These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3116088)

  • 1. Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies.
    Rauch J; Meng QH; Tannenbaum H
    J Immunol; 1987 Oct; 139(8):2598-604. PubMed ID: 3116088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyfunctional properties of hybridoma lupus anticoagulant antibodies.
    Rauch J; Tannenbaum H; Senécal JL; Janoff AS; Cullis PR; Frojmovic MM
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():132-7. PubMed ID: 3112375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets.
    Hasselaar P; Derksen RH; Blokzijl L; de Groot PG
    Thromb Haemost; 1990 Apr; 63(2):169-73. PubMed ID: 2114042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice.
    Ichikawa K; Shimada K; Nawata Y; Ishii T; Tomioka H; Yoshida S; Koike T
    Clin Exp Immunol; 1988 Oct; 74(1):110-4. PubMed ID: 3146452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies: a review.
    Harris EN; Gharavi AE; Asherson RA; Hughes GR
    Eur J Rheumatol Inflamm; 1984; 7(1):5-8. PubMed ID: 6443722
    [No Abstract]   [Full Text] [Related]  

  • 6. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids.
    Rauch J; Tannenbaum M; Janoff AS
    Thromb Haemost; 1989 Nov; 62(3):892-6. PubMed ID: 2512678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies: an elderly statesman Dons new garments.
    Harris EN; Hughes GR; Gharavi AE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():208-13. PubMed ID: 3112376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis].
    Zea Mendoza A; Rodríguez García A; Irigoyen Oyarzábal MV; Vázquez Díaz M; Pardo Vigo A; Mampaso FM; Ortuño Mirete J
    Med Clin (Barc); 1989 May; 92(19):724-8. PubMed ID: 2502695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiphospholipid antibodies, thrombosis and lupus disease. Value of the assay of anticardiolipin antibodies by the ELISA technic].
    Meyer O; Cyna L; Borda-Iriarte O; Jungers P; Piette JC; Dautzenberg MD; Dupuy E; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1985 May; 52(5):297-305. PubMed ID: 3874416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between human hybridoma platelet-binding antibodies derived from systemic lupus erythematosus patients and normal individuals.
    Meng QH; Rauch J
    Autoimmunity; 1990; 5(3):151-67. PubMed ID: 2129749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
    Rauch J; Massicotte H; Tannenbaum H
    J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.
    Tsakiris DA; Settas L; Makris PE; Marbet GA
    J Rheumatol; 1990 Jun; 17(6):785-9. PubMed ID: 2167370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybridoma anti-DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics.
    Rauch J; Massicotte H; Tannenbaum H
    J Immunol; 1985 Jan; 134(1):180-6. PubMed ID: 3964813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-idiotypic antibodies against anti-phospholipid autoantibodies which suppress lupus-like anticoagulant activity.
    Gris JC; Schved JF; Tousch D; Hereil S; Feugeas O
    Nouv Rev Fr Hematol (1978); 1988; 30(3):143-7. PubMed ID: 3138656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiphospholipid antibodies: specificity and mechanism of action].
    Tobelem G
    Ann Med Interne (Paris); 1990; 141(3):257-60. PubMed ID: 2114812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human-human hybridoma autoantibodies with both anti-DNA and rheumatoid factor activities.
    Rauch J; Tannenbaum H; Straaton K; Massicotte H; Wild J
    J Clin Invest; 1986 Jan; 77(1):106-12. PubMed ID: 3511088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary antiphospholipid syndrome: study of 27 patients].
    Barquinero J; Ordi J; Vilardell M; Jordana R; Tolosa C; Selva A; Monasterio Y
    Med Clin (Barc); 1990 Jan; 94(2):41-5. PubMed ID: 2109812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.